Min-Jung Cho

Min-Jung Cho

Auto-generated profile, based on publicly available information

Min-Jung Cho

Department of Pediatrics, Gyeongsang National University Changwon Hospital, Changwon, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JKJinmi Kim
Jinmi Kim
MCMin-Jung Cho
Min-Jung Cho
Korean Circulation Journal 대한심장학회지 순환기 Kim J, et al. Korean Circ J. 2020 Nov;50(11):1013-1022. https://doi.org/10.4070/kcj.2020.0108

29 April 2017 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MCMin-Jung Cho
Min-Jung Cho
JLJi-Won Lee
Ji-Won Lee
JLJeSang Lee
JeSang Lee
YSYong Bum Shin
Yong Bum Shin
HLHyoung Doo Lee
Hyoung Doo Lee

12 July 2018 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MCMin-Jung Cho
Min-Jung Cho
JLJi-Won Lee
Ji-Won Lee
JLJeSang Lee
JeSang Lee
YSYong Beom Shin
Yong Beom Shin

15 November 2024 in Hepatology Communications
Verified
Journal Article
Open access
JSJaehee Seol
Jaehee Seol
JSJinyoung Song
Jinyoung Song
SKSoo-Jin Kim
Soo-Jin Kim
HKHoon Ko
Hoon Ko
JNJae Yoon Na
Jae Yoon Na
SJSe Yong Jung
Se Yong Jung
Background: Despite the development of several imaging modalities for diagnosing Fontan-associated liver disease (FALD), there is no optimal protocol for the follow-up of FALD. We conducted a systematic review and meta-analysis to identify factors related to liver fibrosis using biopsy reports and to identify alternative noninvasive modalities that could better reflect liver histological changes in FALD. Methods: A systematic review and meta-analysis were conducted following the PRISMA guidelines Table S2. We searched Embase, PubMed, and Cochrane databases for studies on FALD, focusing on those assessing clinical factors associated with liver fibrosis severity through liver biopsy and noninvasive imaging techniques. Results: A total of 42 studies were identified, of which 12 conducted meta-analyses and subgroup analyses of the severity of liver fibrosis using liver biopsies. Liver biopsy results showed a weak positive correlation between Fontan duration and fibrosis severity (R = 0.36). Subgroup analyses revealed significant differences in hemodynamic parameters, such as Fontan pressure, between patients with mild and severe fibrosis. Platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index were significantly associated with fibrosis severity, with severe fibrosis showing lower platelet counts and higher aspartate aminotransferase to platelet ratio index and fibrosis-4 index levels. Noninvasive imaging modalities, particularly magnetic resonance elastography and shear wave elastography, demonstrated strong correlations with biopsy-confirmed fibrosis severity. Conclusions: This study identifies key clinical factors, and noninvasive modalities accurately reflect liver fibrosis severity in patients with FALD. Clinical factors such as platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index may aid in identifying patients at risk for severe fibrosis. In addition, magnetic resonance elastography and shear wave elastography are promising tools for noninvasive assessment in our study. Further research is needed to refine these diagnostic approaches and improve patient management.

1 January 2017 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
WYWoo Hyun Yoo
Woo Hyun Yoo
MCMin-Jung Cho
Min-Jung Cho
PCPeter Chun
Peter Chun
KKKwang Hun Kim
Kwang Hun Kim
JLJe Sang Lee
Je Sang Lee
YSYong Beom Shin
Yong Beom Shin
Myocardial dysfunction and dysrhythmias are inevitable consequences of Duchenne muscular dystrophy. We aimed to evaluate specific trends of electrocardiographic changes that reflect the progress of cardiomyopathy in patients with Duchenne muscular dystrophy. Fifty electrocardiograms (ECGs) of 30 patients (ages 1 to 27 years) who had not been prescribed medications for heart failure treatment at the time of examination were retrospectively analyzed and compared with 116 ECGs of age-matched healthy 116 controls. Heart rate, leads with fragmented QRS (fQRS), corrected QT, Tpeak-to-Tend, and Tpeak-to-Tend/QT were analyzed. The patients with Duchenne muscular dystrophy failed to show a normal age-related decline in heart rate but showed an increasing trend in the prevalence of fQRS, corrected QT, corrected Tpeak-to-Tend, and Tpeak-to-Tend/QT over time. In the ≤10-year-old patient group, a significant difference was found only in the prevalence of fQRS between the patients and the controls. The prevalence of fQRS, heart rate, Tpeak-to-Tend/QT, and corrected Tpeak-to-Tend demonstrated significant differences between the patients and the controls in the middle age group (11 to 15 years old). All the indexes were statistically significantly different in the ≥16-year-old patient group. The prevalence of lead with fQRS representing regional wall motion abnormalities was higher in the young patients than in the young healthy controls, and this might be one of the first signs of myocardial change in the patients. Markers of depolarization and repolarization abnormalities were gradually prominent in the patients aged >10 years. Further studies are needed to confirm these findings.

15 October 2009 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MCMin Jung Cho
Min Jung Cho
JPJi Ae Park
Ji Ae Park
HLHyoung Doo Lee
Hyoung Doo Lee